MannKind News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.11.24	MannKind Corp. Q3 Profit Increases, Beats Estimates (RTTNews)
30.09.24	MannKind Reports 30-week Results From Phase 4 INHALE-3 Study - Quick Facts (RTTNews)
20.09.24	EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? (RTTNews)
19.09.24	ACLX, HROW Deliver Triple-Digit Returns - Did You Cash In? (RTTNews)
29.05.24	Pulmatrix Enters Cross License Agreement With MannKind - Quick Facts (RTTNews)
08.05.24	MannKind Corp. Q1 Earnings Summary (RTTNews)
29.04.24	MannKind Gets FDA Nod For Phase 3 Study Of Clofazimine Inhalation Suspension For NTM Lung Disease (RTTNews)
27.02.24	MannKind Corp. Q4 Earnings Summary (RTTNews)
02.01.24	MannKind Corp.: Sagard Healthcare Purchases 1% Royalty In Tyvaso DPI Net Sales (RTTNews)
07.11.23	MannKind Corp. Q3 Earnings Summary (RTTNews)
10.08.23	These 11 Biotech Stocks Hit New Highs - Are They In Your Portfolio? (RTTNews)
07.08.23	MannKind Corp. Q2 Earnings Summary (RTTNews)
10.05.23	MannKind Corp. Q1 Loss decreases, beats estimates (RTTNews)
23.02.23	MannKind Corp. Q4 Loss decreases, but misses estimates (RTTNews)
08.11.22	MannKind Corp. Q3 Loss increases, but beats estimates (RTTNews)
17.05.22	MannKind Corp. To Acquire V-Go From Zealand Pharma - Quick Facts (RTTNews)
05.05.22	MannKind Corp. Q1 loss increases in line with estimates (RTTNews)
24.02.22	MannKind Corp. Loss at -$28.06 Mln in Q4 (RTTNews)
09.11.21	MannKind Corp. Q3 adjusted earnings Beat Estimates (RTTNews)
04.10.21	MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population (PR Newswire)
07.09.21	United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021 (PR Newswire)
11.08.21	MannKind Corp. Q2 adjusted earnings Miss Estimates (RTTNews)
04.08.21	MannKind Partners With NRx Pharma To Explore Dry Powder Formulation Of ZYESAMI (RTTNews)
04.08.21	MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform (PR Newswire)
04.08.21	NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions (PR Newswire)
28.06.21	Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18 (PR Newswire)
25.06.21	MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29 (PR Newswire)
16.06.21	MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA (PR Newswire)
16.06.21	United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review (PR Newswire)
19.04.21	United Therapeutics Files New Drug Application For Tyvaso DPI- Quick Fats (RTTNews)
02.03.21	FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals (RTTNews)
25.02.21	MannKind Corp. Posts Adj. Loss In Q4 (RTTNews)
10.12.20	MannKind Appoints James Shannon As Chairman (RTTNews)
13.11.20	AZN's Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoV (RTTNews)
07.05.20	EARNINGS SUMMARY: Details of MannKind Corp. Q1 Earnings Report (RTTNews)
17.03.20	MannKind Collaborates With Immix Biopharma To Combat COVID-19 - Quick Facts (RTTNews)
25.02.20	MannKind Corp. Posts Wider Loss In Q4 - Quick Facts (RTTNews)
06.11.19	EARNINGS SUMMARY: Details of MannKind Corp. Q3 Earnings Report (RTTNews)
07.08.19	EARNINGS SUMMARY: Details of MannKind Corp. Q2 Earnings Report (RTTNews)
07.05.19	EARNINGS SUMMARY: Details of MannKind Corp. Q1 Earnings Report (RTTNews)
26.02.19	EARNINGS SUMMARY: Details of MannKind Corp. Q4 Earnings Report (RTTNews)
20.12.18	7 Stocks That Made Big Moves After-hours (TLRY, SPPI, ADMA, DBVT...) (RTTNews)
01.11.18	EARNINGS SUMMARY: Details of MannKind Corp. Q3 Earnings Report (RTTNews)
05.09.18	MNKD Takes Giant Leap, REPH On Watch, ALRN To Report Study Data In Q4 (RTTNews)
04.09.18	United Therapeutics, MannKind Enter Licensing Agreement For Treprostinil (RTTNews)
25.06.18	LLY Scores Win In Alimta Patent Suit, LXRX For The Long Haul, MNKD Breathes Easy (RTTNews)
23.06.18	MannKind Reports Positive Afrezza Data From STAT, AFFINITY Studies (RTTNews)
08.06.18	FDA Nod For EDAP, AGRX Issues Pink Slips, APHB Turns Heads, MNKD Breathes Easy (RTTNews)
09.05.18	EARNINGS SUMMARY: Details of MannKind Corp. Q1 Earnings Report (RTTNews)
27.02.18	EARNINGS SUMMARY: Details of MannKind Corp. Q4 Earnings Report (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MannKind

Aktien Top/Flop

Meistgelesene Nachrichten